Latest Research in Natural product bioactivities and synthesis
15 research papers · 2026 median publication year
Top Research Topics in Natural product bioactivities and synthesis
- Natural product bioactivities and synthesis — 2 papers
- Myeloproliferative Neoplasms: Diagnosis and Treatment — 1 papers
- Fungal Biology and Applications — 1 papers
- Probiotics and Fermented Foods — 1 papers
- Metalloenzymes and iron-sulfur proteins — 1 papers
- Diabetes Treatment and Management — 1 papers
- Machine Learning — 1 papers
- Pharmacological Effects of Medicinal Plants — 1 papers
- Malaria Research and Control — 1 papers
- Mass Spectrometry Techniques and Applications — 1 papers
Highest-Cited Papers
- Simple LC-MS/MS Method for Ruxolitinib in Human Plasma and Its Clinical Application in Pediatric and Adult Patients
- Molecular characterization of a novel fungal immunomodulatory protein from Ganoderma cf. resinaceum: cloning, heterologous expression and bioactivity
- Global biogeography of Bifidobacterium infantis : stratification and precision probiotic design
- Triterpene-based bioconjugates in cancer studies: a scoping review of preclinical evidence-review protocol
- Triterpene-based bioconjugates in cancer studies: a scoping review of preclinical evidence-review protocol
- Electronic-Structure Determinants of Flavonoid Inhibition at the Molybdenum Cofactor of Xanthine Oxidase: A QM/MM Study
- Potential DPP-IV inhibitors for type 2 diabetes mellitus: an integrated computational and experimental pipeline
- Multi-Level-Set-Based Physics-Driven Neural Network to Solve 3-D Inverse Scattering Problems
- Biomphalaria glabrata as a possible experimental model for investigating anti-inflammatory substances
- Pharmacokinetics and Toxicity Assessment of Artesunate and Its Metabolite, Dihydroartemisinin, in NOD Scid Gamma Mice
- MALDI MSI Workflow for Pharmaceutical Tablets: Toward a Reproducible Strategy for High-Resolution Imaging
- Pharmacokinetics and safety comparison of cycloserine capsules and their generic counterpart: a randomized, open-label, two-period, two-sequence, single-dose crossover bioequivalence study in healthy Chinese subjects
- An asymptotic model for drug dissolution in a standardized flow-through apparatus
- Pharmacokinetics and bioequivalence of rasagiline mesylate tablets in healthy Chinese subjects under fasting and fed conditions: an open, randomized, single-dose, four-period crossover clinical trial
- The 95% CDIRAs , a Credible Interval Based Method to Capture Uncertainty in Population Modeling: Pharmacokinetics Versus Sum of Exponentials Case Study